Insider Trading activities of Amylin Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amylin Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Amylin Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Amylin Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AMLN. The reporting company's CIK number is 881464.
The total value of stock buying since 2005 is $166,931,228.
The total value of stock sales since 2005 is $345,994,933.
The total value of stock option exercises since 2005 is $11,112,250.


Go to page:  1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Amylin Pharmaceuticals Inc (AMLN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-07 0 $0 0 $0 56,300 $672,785
2012-05 0 $0 0 $0 18,000 $167,040
2012-03 0 $0 20,616 $405,007 5,000 $45,100
2012-02 0 $0 63,142 $1,067,438 0 $0
2012-01 0 $0 1,832 $21,232 5,993 $0
2011-10 0 $0 15,000 $131,220 62,500 $358,125
2011-05 0 $0 0 $0 3,000 $33,090
2011-03 0 $0 13,750 $206,525 13,750 $128,246
2011-02 0 $0 12,500 $202,035 12,500 $139,060
2011-01 0 $0 3,170 $47,509 2,500 $27,812
2010-11 0 $0 1,314 $17,633 25,000 $278,125
2010-05 0 $0 0 $0 10,000 $102,500
2010-04 0 $0 0 $0 638 $8,453
2010-03 0 $0 0 $0 5,000 $48,125
2010-02 0 $0 0 $0 72,606 $1,036,886
2009-09 0 $0 3,853,880 $54,287,588 0 $0
2009-02 0 $0 0 $0 16,344 $12,764
2008-08 0 $0 10,309,375 $217,453,877 100 $1,654
2008-06 261,207 $7,815,313 0 $0 0 $0
2008-05 416,619 $11,623,670 40,000 $1,280,090 0 $0
2008-04 4,502,240 $131,997,310 60,000 $1,925,620 0 $0
2008-03 459,881 $12,639,294 0 $0 5,608 $13,711
2008-02 75,000 $2,014,300 8,308 $254,047 76,724 $326,259
2008-01 0 $0 40,100 $1,408,331 14,700 $105,497
2007-12 0 $0 41,100 $1,551,648 22,700 $148,395
2007-11 0 $0 44,600 $1,838,190 96,645 $443,628
2007-10 0 $0 51,800 $2,510,251 20,700 $214,490
2007-09 0 $0 56,100 $2,744,786 30,150 $303,238
2007-08 0 $0 109,914 $5,427,298 73,700 $858,126
2007-07 0 $0 50,892 $2,188,094 163,200 $582,607
2007-06 0 $0 53,892 $2,406,633 39,098 $486,521
2007-05 0 $0 84,618 $3,679,999 49,200 $571,623
2007-04 0 $0 54,738 $2,196,776 20,700 $118,979
2007-03 0 $0 41,892 $1,573,307 50,969 $482,549
2007-02 0 $0 27,892 $1,107,171 16,700 $140,907
2007-01 0 $0 25,192 $990,690 133,479 $409,497
2006-12 0 $0 32,692 $1,254,682 29,673 $354,844
2006-11 0 $0 68,192 $2,963,196 17,500 $142,856
2006-10 0 $0 62,038 $2,752,057 17,500 $163,626
2006-09 0 $0 62,525 $2,849,235 18,500 $173,175
2006-08 0 $0 79,038 $3,498,594 21,593 $175,972
2006-07 0 $0 61,038 $2,974,139 8,500 $91,454
2006-06 0 $0 30,846 $1,417,078 18,869 $286,120
2006-05 0 $0 66,384 $2,842,093 18,000 $76,945
2006-04 0 $0 59,692 $2,758,785 23,000 $121,569
2006-03 0 $0 58,192 $2,587,719 19,500 $81,126
2006-02 0 $0 97,846 $3,951,179 54,154 $72,276
2006-01 0 $0 65,121 $2,735,444 100,555 $1,086,930
2005-12 0 $0 39,940 $1,543,914 3,500 $19,565
2005-11 0 $0 39,692 $1,420,951 0 $0
2005-10 0 $0 34,692 $1,215,665 0 $0
2005-09 0 $0 34,692 $1,112,681 0 $0
2005-08 0 $0 13,538 $317,177 0 $0
2005-07 0 $0 9,192 $196,042 0 $0
2005-06 0 $0 31,692 $604,387 0 $0
2005-05 50,000 $841,341 0 $0 0 $0
2005-03 0 $0 3,846 $76,920 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Amylin Pharmaceuticals Inc insiders (AMLN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-07-26 Bradbury Daniel (President & Chief Executive Of) Option Ex 36,000 11.95 430,200
2012-07-26 Kolterman Orville G (SVP, Chief Medical Officer) Option Ex 20,300 11.95 242,585
2012-05-11 Skyler Jay S (Director) Option Ex 18,000 9.28 167,040
2012-03-29 Rowland Lloyd A (VP, Chief Compliance Officer) Sale 3,000 25.00 75,000
2012-03-28 Rowland Lloyd A (VP, Chief Compliance Officer) Sale 5,000 22.83 114,149
2012-03-28 Rowland Lloyd A (VP, Chief Compliance Officer) Option Ex 5,000 9.02 45,100
2012-03-01 Weyer Christian (SVP, Research & Development) Sale 1,231 17.11 21,062
2012-03-01 Mihalik Vincent P (SVP, Chief Commercial Officer) Sale 1,231 17.11 21,062
2012-03-01 Lloyd Marcea Bland (SVP, Chief Administrative Officer) Sale 1,846 17.11 31,585
2012-03-01 Gergen Mark J (SVP, Corporate Development) Sale 1,846 17.11 31,585
2012-03-01 Leonhardt Harry J (SVP, Legal, Compliance and Cor) Sale 1,231 17.11 21,062
2012-03-01 Bradbury Daniel (President & Chief Executive Of) Sale 1,539 17.11 26,332
2012-03-01 Kolterman Orville G (SVP, Chief Medical Officer) Sale 1,846 17.11 31,585
2012-03-01 Foletta Mark G (SVP, Chief Financial Officer) Sale 1,846 17.11 31,585
2012-02-23 Weyer Christian (SVP, Research & Development) Sale 2,519 17.03 42,898
2012-02-23 Mihalik Vincent P (SVP, Chief Commercial Officer) Sale 7,518 17.03 128,031
2012-02-23 Lloyd Marcea Bland (SVP, Chief Administrative Officer) Sale 7,518 17.03 128,031
2012-02-23 Marshall Paul (SVP, Operations) Sale 5,638 17.03 96,015
2012-02-23 Gergen Mark J (SVP, Corporate Development) Sale 7,518 17.03 128,031
2012-02-23 Leonhardt Harry J (SVP, Legal, Compliance and Cor) Sale 2,180 17.03 37,125
2012-02-23 Kolterman Orville G (SVP, Chief Medical Officer) Sale 5,638 17.03 96,015
2012-02-23 Foletta Mark G (SVP, Chief Financial Officer) Sale 5,638 17.03 96,015
2012-02-08 Weyer Christian (SVP, Research & Development) Sale 3,843 16.62 63,851
2012-02-08 Mihalik Vincent P (SVP, Chief Commercial Officer) Sale 3,842 16.62 63,838
2012-02-08 Lloyd Marcea Bland (SVP, Chief Administrative Officer) Sale 5,653 16.62 93,930
2012-02-08 Kolterman Orville G (SVP, Chief Medical Officer) Sale 5,637 16.62 93,658
2012-01-17 Denner Alexander J (Director) Sale 1,832 11.59 21,232
2012-01-17 Denner Alexander J (Director) Option Ex 5,993 .00 0
2011-10-04 Bradbury Daniel (President & Chief Executive Of) Option Ex 45,000 5.73 257,850
2011-10-04 Kolterman Orville G (SVP, Chief Medical Officer) Option Ex 2,500 5.73 14,325
2011-10-03 Kolterman Orville G (SVP, Chief Medical Officer) Sale 15,000 8.75 131,220
2011-10-03 Kolterman Orville G (SVP, Chief Medical Officer) Option Ex 15,000 5.73 85,950
2011-05-24 Skyler Jay S (Director) Option Ex 3,000 11.03 33,090
2011-03-01 Kolterman Orville G (SVP, Chief Medical Officer) Sale 13,750 15.02 206,525
2011-03-01 Kolterman Orville G (SVP, Chief Medical Officer) Option Ex 13,750 9.33 128,246
2011-02-01 Kolterman Orville G (SVP, Chief Medical Officer) Sale 7,500 16.16 121,221
2011-02-01 Kolterman Orville G (SVP, Chief Medical Officer) Option Ex 7,500 11.12 83,436
2011-01-18 Kolterman Orville G (SVP, Chief Medical Officer) Sale 2,500 15.00 37,500
2011-01-18 Kolterman Orville G (SVP, Chief Medical Officer) Option Ex 2,500 11.12 27,812
2011-01-18 Gavin James R Iii (Director) Sale 670 14.94 10,009
2010-11-22 Bradbury Daniel (President & Chief Executive Of) Option Ex 25,000 11.12 278,125
2010-11-19 Weyer Christian (SVP, Research & Development) Sale 1,314 13.42 17,633
2010-05-28 Skyler Jay S (Director) Option Ex 10,000 10.25 102,500
2010-04-06 Foletta Mark G (SVP, Chief Financial Officer) Option Ex 638 13.25 8,453
2010-03-25 Bradbury Daniel (President & Chief Executive Of) Option Ex 5,000 9.62 48,125
2010-02-19 Kolterman Orville G (SVP Research & Development) Option Ex 25,000 14.28 357,025
2010-02-18 Bradbury Daniel (President & Chief Executive Of) Option Ex 47,606 14.28 679,861
2009-09-17 Eastbourne Capital Management Llc/ca (10% Owner) Sale 1,443,241 13.96 20,150,530
2009-09-16 Eastbourne Capital Management Llc/ca (10% Owner) Sale 2,410,639 14.16 34,137,058
2009-02-26 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 16,344 .78 12,764
2008-08-27 Black Bear Offshore Master Fund Lp Sale 4,192,713 21.00 88,030,202
2008-08-27 Eastbourne Capital Management Llc/ca Sale 6,026,562 21.00 126,533,695
2008-08-18 Rowland Lloyd A (VP Governance Compliance & Cor) Sale 100 35.00 3,500
2008-08-18 Rowland Lloyd A (VP Governance Compliance & Cor) Option Ex 100 16.54 1,654
2008-08-08 Cook Joseph C Jr (Director) Sale 60,000 32.07 1,924,320
2008-06-06 Black Bear Offshore Master Fund Lp Buy 111,207 29.92 3,327,313
2008-06-06 Eastbourne Capital Management Llc/ca Buy 150,000 29.92 4,488,000
2008-05-29 Cook Joseph C Jr (Director) Sale 10,000 32.00 320,000
2008-05-16 Cook Joseph C Jr (Director) Sale 30,000 32.00 960,090
2008-05-07 Black Bear Offshore Master Fund Lp Buy 166,619 27.90 4,648,670
2008-05-07 Eastbourne Capital Management Llc/ca Buy 250,000 27.90 6,975,000
2008-04-30 Black Bear Offshore Master Fund Lp Buy 356,652 27.72 9,886,393
2008-04-30 Eastbourne Capital Management Llc/ca Buy 356,652 27.72 9,886,393
2008-04-21 Black Bear Offshore Master Fund Lp (10% Owner) Buy 894,000 29.04 25,957,290
2008-04-21 Eastbourne Capital Management Llc/ca (10% Owner) Buy 894,000 29.04 25,957,290
2008-04-17 Black Bear Offshore Master Fund Lp (10% Owner) Buy 50,000 30.35 1,517,500
2008-04-17 Eastbourne Capital Management Llc/ca (10% Owner) Buy 50,000 30.35 1,517,500
2008-04-16 Black Bear Offshore Master Fund Lp (10% Owner) Buy 19,471 30.78 599,317
2008-04-16 Eastbourne Capital Management Llc/ca (10% Owner) Buy 19,471 30.78 599,317
2008-04-15 Black Bear Offshore Master Fund Lp (10% Owner) Buy 28,689 29.27 839,727
2008-04-15 Eastbourne Capital Management Llc/ca (10% Owner) Buy 28,689 29.27 839,727
2008-04-14 Black Bear Offshore Master Fund Lp (10% Owner) Buy 147,308 29.42 4,333,212
2008-04-14 Eastbourne Capital Management Llc/ca (10% Owner) Buy 147,308 29.42 4,333,212
2008-04-11 Black Bear Offshore Master Fund Lp (10% Owner) Buy 291,300 29.98 8,733,756
2008-04-11 Eastbourne Capital Management Llc/ca (10% Owner) Buy 291,300 29.98 8,733,756
2008-04-09 Black Bear Offshore Master Fund Lp (10% Owner) Buy 208,700 30.05 6,271,435
2008-04-09 Eastbourne Capital Management Llc/ca (10% Owner) Buy 208,700 30.05 6,271,435
2008-04-08 Black Bear Offshore Master Fund Lp (10% Owner) Buy 50,000 30.96 1,548,000
2008-04-08 Eastbourne Capital Management Llc/ca (10% Owner) Buy 50,000 30.96 1,548,000
2008-04-07 Black Bear Offshore Master Fund Lp (10% Owner) Buy 50,000 31.52 1,576,000
2008-04-07 Eastbourne Capital Management Llc/ca (10% Owner) Buy 50,000 31.52 1,576,000
2008-04-04 Cook Joseph C Jr (Director) Sale 30,000 32.01 960,330
2008-04-03 Black Bear Offshore Master Fund Lp (10% Owner) Buy 155,000 30.56 4,736,025
2008-04-03 Eastbourne Capital Management Llc/ca (10% Owner) Buy 155,000 30.56 4,736,025
2008-04-01 Cook Joseph C Jr (Director) Sale 10,000 32.51 325,070
2008-03-28 Black Bear Offshore Master Fund Lp (10% Owner) Buy 118,933 28.10 3,342,017
2008-03-28 Eastbourne Capital Management Llc/ca (10% Owner) Buy 118,933 28.10 3,342,017
2008-03-26 Eastbourne Capital Management Llc/ca (10% Owner) Buy 41,067 28.06 1,152,134
2008-03-25 Eastbourne Capital Management Llc/ca (10% Owner) Buy 90,000 28.61 2,574,900
2008-03-17 Eastbourne Capital Management Llc/ca (10% Owner) Buy 60,632 24.50 1,485,484
2008-03-10 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,608 2.44 13,711
2008-02-29 Eastbourne Capital Management Llc/ca (10% Owner) Buy 50,000 26.59 1,329,300
2008-02-28 Eastbourne Capital Management Llc/ca (10% Owner) Buy 25,000 27.40 685,000
2008-02-19 Greene Howard E Jr (Director) Sale 3,700 28.74 106,330
2008-02-11 Greene Howard E Jr (Director) Option Ex 10,000 4.38 43,750
2008-02-05 Cook Joseph C Jr (Director) Option Ex 66,724 4.23 282,509
2008-02-04 Graham Ginger L (Director) Sale 908 31.98 29,040
2008-02-04 Greene Howard E Jr (Director) Sale 3,700 32.08 118,677
2008-01-22 Baron Alain D (Sr VP Research) Option Ex 2,000 7.19 14,374
2008-01-22 Cook Joseph C Jr (Director) Sale 10,000 32.60 325,980
2008-01-22 Greene Howard E Jr (Director) Sale 3,700 33.08 122,392
2008-01-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,000 35.42 212,495
2008-01-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,000 1.84 11,058
2008-01-07 Greene Howard E Jr (Director) Sale 3,700 35.55 131,538
2008-01-03 Cook Joseph C Jr (Director) Sale 10,000 36.67 366,680
2008-01-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 37.20 249,246
2008-01-02 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 11.95 80,065
2007-12-24 Greene Howard E Jr (Director) Sale 3,700 38.23 141,458
2007-12-20 Baron Alain D (Sr VP Research) Option Ex 9,000 7.19 64,683
2007-12-18 Cook Joseph C Jr (Director) Sale 10,000 37.72 377,180
2007-12-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 38.39 191,950
2007-12-17 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 5.73 28,650
2007-12-10 Greene Howard E Jr (Director) Sale 3,700 39.05 144,499
2007-12-04 Cook Joseph C Jr (Director) Sale 10,000 36.86 368,600
2007-12-03 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 37.56 75,110
2007-12-03 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 16.54 33,080
2007-12-03 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 37.74 252,851
2007-12-03 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 3.28 21,982
2007-11-26 Greene Howard E Jr (Director) Sale 3,700 39.05 144,488
2007-11-20 Cook Joseph C Jr (Director) Sale 10,000 38.71 387,060
2007-11-19 Baron Alain D (Sr VP Research) Sale 1,000 40.50 40,500
2007-11-19 Baron Alain D (Sr VP Research) Option Ex 1,000 18.85 18,850
2007-11-16 Bradbury Daniel (President & Chief Exec Officer) Option Ex 9,445 14.28 134,884
2007-11-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 41.68 208,390
2007-11-15 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 5.73 28,650
2007-11-14 Cook Joseph C Jr (Director) Option Ex 70,000 2.66 185,920
2007-11-12 Greene Howard E Jr (Director) Sale 3,700 40.44 149,609
2007-11-05 Cook Joseph C Jr (Director) Sale 10,000 41.49 414,920
2007-11-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 44.00 22,000
2007-11-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-11-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Sale 2,000 44.16 88,310
2007-11-01 Rowland Lloyd A (VP, Gov/Compliance, Secretary) Option Ex 2,000 16.54 33,080
2007-11-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 6,700 44.02 294,913
2007-11-01 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 6,700 2.91 19,470
2007-11-01 Baron Alain D (Sr VP Research) Sale 2,000 44.00 88,000
2007-11-01 Baron Alain D (Sr VP Research) Option Ex 2,000 7.19 14,374
2007-10-29 Greene Howard E Jr (Director) Sale 3,700 46.46 171,913
2007-10-18 Baron Alain D (Sr VP Research) Sale 1,000 45.94 45,940
2007-10-18 Baron Alain D (Sr VP Research) Option Ex 1,000 18.85 18,850
2007-10-18 Cook Joseph C Jr (Director) Sale 10,000 46.00 459,960
2007-10-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Sale 5,000 47.70 238,475
2007-10-16 Kolterman Orville G (Sr VP Clinical and Regulatory) Option Ex 5,000 5.73 28,650
2007-10-15 Greene Howard E Jr (Director) Sale 3,700 47.90 177,222
2007-10-03 Gergen Mark J (Sr VP, Corporate Development) Sale 500 50.00 25,000
2007-10-03 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
2007-10-03 Baron Alain D (Sr VP Research) Sale 1,000 50.00 50,000
2007-10-03 Baron Alain D (Sr VP Research) Option Ex 1,000 7.19 7,187
2007-10-03 Cook Joseph C Jr (Director) Sale 10,000 50.17 501,659
2007-10-01 Gergen Mark J (Sr VP, Corporate Development) Sale 500 49.83 24,915
2007-10-01 Gergen Mark J (Sr VP, Corporate Development) Option Ex 500 16.80 8,400
Go to page:  1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of AMLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Amylin Pharmaceuticals Inc (symbol AMLN, CIK number 881464) see the Securities and Exchange Commission (SEC) website.